CD4 and Cognitive impairment: The current cohort of PWH entered the CHARTER cohort between 2003 and 2007 and the participants were considered to be already at higher risk of cognitive impairment due to the ART initiation guidelines in place at that time, which were based on low CD4+ T cell counts.